UBS O'Connor’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-102,755
Closed -$51K 807
2021
Q4
$51K Buy
102,755
+2,756
+3% +$1.52K ﹤0.01% 909
2021
Q3
$57K Hold
99,999
﹤0.01% 877
2021
Q2
$69K Hold
99,999
﹤0.01% 855
2021
Q1
$47K Buy
+99,999
New +$47.8K ﹤0.01% 795

Other funds holding ISLEW

UBS O'Connor's ISLEW Position: Q1 2022 in Review

UBS O'Connor sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q1 2022, closing a stake of 102,755 shares — an estimated $51K sold.

UBS O'Connor first reported a position in ISLEW in Q1 2021 and held it in 4 quarters. The position peaked at $69K in Q2 2021. 45 funds tracked by Wall St. Rank hold ISLEW as of Q1 2022.

  • UBS O'Connor reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 102,755 Isleworth Healthcare Acquisition Corporation Warrant shares in Q1 2022, an estimated $51K.
  • UBS O'Connor first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q1 2021 and held it in 4 quarters.
  • UBS O'Connor's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $69K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.